What one share of TransMedics Group holds
We are a medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. We developed the OCS to replace a decades-old standard of care that we believe is significantly limiting access to life-saving transplant therapy for hundreds of thousands of patients worldwide.
TransMedics Group’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $17.39 |
|---|---|
| Profit | $4.01 |
| Capex (buildings and equipment) | $1.74 |
| Free cash flow | $2.06 |
| Cash and investments | $14.18 |
| Book value | $14.96 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | $9.58 | −$17.48 | $0.31 | −$19.43 | — | −$137.56 |
| 2019 | $1.66 | −$2.36 | $0.01 | −$2.28 | $0.00 | $2.58 |
| 2020 | $1.04 | −$1.16 | $0.02 | −$1.24 | $0.00 | $3.82 |
| 2021 | $1.10 | −$1.60 | $0.13 | −$1.17 | $0.00 | $2.44 |
| 2022 | $3.16 | −$1.23 | $0.40 | −$1.95 | $0.00 | $5.83 |
| 2023 | $7.43 | −$0.77 | $4.67 | −$5.07 | $0.00 | $4.20 |
| 2024 | $12.54 | $1.01 | $3.68 | −$2.30 | $0.00 | $6.80 |
| 2025 | $14.94 | $4.87 | $1.46 | $3.30 | $0.00 | $13.81 |
Common questions about TransMedics Group
How much does one share of TransMedics Group earn?
Over the last 12 months, each share of TransMedics Group earned $4.01 of profit on $17.39 of sales, keeping about 23¢ of every $1 (profit margin).
Does TransMedics Group pay a dividend?
TransMedics Group didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is TransMedics Group’s book value per share?
TransMedics Group’s book value is $14.96 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of TransMedics Group have?
Each share of TransMedics Group has $14.18 of cash and investments, as of June 30, 2026.
What is TransMedics Group’s free cash flow per share?
$2.06 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has TransMedics Group bought back shares?
TransMedics Group’s share count rose about 2884% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.